文献速递主动脉疾病

胸主动脉腔内修复术长期经验的综合学习曲线分析

Comprehensive Learning Curve Analysis of a Long-Term Experience With Thoracic Endovascular Aneurysm Repair.
PubMed 文献 · J Endovasc Ther · 2023-03-24

该单中心回顾性观察研究纳入1996年至2021年间390例连续标准胸主动脉腔内修复术(TEVAR),用累积和图表分析学习曲线。中心学习曲线在第75例后达成,首位植入医师相似,后续医师曲线显著缩短至10例。Q3-Q4较Q1-Q2的30天死亡率、术中附加操作和晚期内漏及主动脉相关死亡率显著降低,手术时间、透视时间和对比剂用量从Q1到Q4显著减少。

要点

  • 中心及首位医师的TEVAR学习曲线在第75例后达成,后续医师曲线缩短至10例。
  • Q3-Q4较Q1-Q2的30天死亡率(3.6% vs 11.4%)、术中附加操作(13.3% vs 21.5%)显著降低。
  • Q1到Q4手术时间、透视时间和对比剂用量显著减少。

核心结论

  • 学习曲线随时间显著缩短,临床结局改善不可忽视,提示需专门血管腔内训练才能成为有效的TEVAR术者。

研究设计与样本

  • 单中心回顾性观察研究,纳入1996年至2021年间390例连续标准TEVAR手术。
  • 对全中心经验以及第一和第二植入医师分别绘制累积和图表。
  • 按经验四分位数(Q1-Q4)或前2 vs 后2四分位(Q1-Q2 vs Q3-Q4)分析次要结局。

主要发现

  • 平均随访4.3±4.0年,中心学习曲线在75例后达成,首位植入医师相似,后续医师曲线显著缩短(10例TEVAR)。
  • Q1-Q2 vs Q3-Q4:30天主要不良事件16.1% vs 11.3%(p=0.164),30天死亡率11.4% vs 3.6%(p=0.003),术中附加操作21.5% vs 13.3%(p=0.033),临床成功率85.9% vs 90.3%(p=0.190)。
  • Q1到Q4:手术时间139.8±65.5至76.7±43.7分钟(p=0.001),透视时间15.1±8.8至7.1±5.1分钟(p<0.001),对比剂用量244.0±112.1至104.3±46.1 mL(p<0.001)。
  • Q1-Q2 vs Q3-Q4:晚期内漏24.1% vs 15.5%(p=0.033),主动脉相关死亡率18.6% vs 8.2%(p=0.006)。
  • 手术时间(p=0.021)、对比剂用量(p=0.016)和透视时间(p=0.004)是内漏的独立危险因素,每增加60分钟手术时间风险增加1.3倍(p=0.021),每增加100 mL对比剂风险增加1.3倍(p=0.016),每增加10分钟透视时间风险增加1.4倍(p=0.004)。

临床怎么用

  • 作者认为,专门血管腔内训练是成为有效TEVAR术者的必要条件。
  • 首次开展TEVAR的中心和培训项目提供者可利用这些数据以提供更好的临床结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To analyze the learning curve for thoracic endovascular aortic repair (TEVAR) in a single center over a period of 25 years. MATERIALS AND METHODS: In total, 390 consecutive standard TEVAR procedures undertaken between 1996 and 2021 were included in a retrospective, observational, single-center study. Cumulative sum charts were elaborated for the entire center experience (primary outcome) as well as for the first and second implanting physicians. Data on procedural variables (contrast volume, operative and fluoroscopy time), 30-day major adverse events (MAEs) and clinical success, and endoleak and reintervention rates were secondary outcomes and subdivided into 4 quartiles of experience (Q1-Q4) or presented as first 2 versus latest 2 quartiles (Q1-Q2 vs Q3-Q4). RESULTS: The mean follow-up was 4.3±4.0 years. The center's learning curve was achieved after 75 procedures, and it was similar for the first implanting physician. The surgeon coming thereafter had a significantly shorter curve (10 TEVARs). Comparing Q1-Q2 with Q3-Q4, 30-day MAEs (16.1 vs 11.3%, p=0.164), 30-day mortality (11.4% vs 3.6%, p=0.003), and intraoperative additional maneuvers (21.5% vs 13.3%, p=0.033) were reduced along with an improvement in clinical success (85.9% vs 90.3%, p=0.190). From Q1 to Q4, operative time (139.8±65.5 to 76.7±43.7 min, p=0.001), fluoroscopy time (15.1±8.8 to 7.1±5.1 min, p<0.001), and contrast volume (244.0±112.1 to 104.3±46.1 mL, p<0.001) showed a considerable reduction. Late endoleak and aortic-related mortality declined significantly from Q1-Q2 to Q3-Q4 (24.1% to 15.5%, p=0.033 and 18.6% vs 8.2%, p=0.006, respectively). Operative time (p=0.021), contrast volume (p=0.016), and fluoroscopy time (p=0.004) were independent risk factors for endoleak, causing a 1.3-fold risk increase for both each 60 minutes of additional operative time (p=0.021) and every 100 mL of additional contrast medium (p=0.016). Each 10-minute increase in fluoroscopy time determined a 1.4-fold risk increment (p=0.004). CONCLUSION: The learning curve shortened significantly over time with non-negligible clinical outcome improvements, suggesting that specific endovascular training is mandatory to become an effective TEVAR performer. CLINICAL IMPACT: For the first time in literature, the standard TEVAR's learning curve has been evaluated at a single vascular surgery center over a period of 25 years. The learning curve for the center and the first physician historically undertaking TEVAR was achieved at the 75th treated patient. The learning curve of the surgeons coming thereafter was significantly shorter (10 cases). This quarter-century demonstrated that intraoperative learning-related variables were associated with long-term clinical outcomes and all have improved over time. Centers approaching TEVAR for the first time and training program providers could use these data to aim to offer better clinical outcomes.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Gennai S, Leone N, Bartolotti LA, et al. Comprehensive Learning Curve Analysis of a Long-Term Experience With Thoracic Endovascular Aneurysm Repair. J Endovasc Ther. 2023. PMID: 36960843. doi:10.1177/15266028231161489

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。